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Background. Taking into account the probable role that race/skin color may have for determining outcomes in maternal health,
the objective of this study was to assess whether maternal race/skin color is a predictor of severe maternal morbidity. Methods.
This is a secondary analysis of the Brazilian Network for Surveillance of Severe Maternal Morbidity, a national multicenter cross-
sectional study of 27 Brazilian referral maternity hospitals. A prospective surveillance was performed to identify cases of maternal
death (MD), maternal near miss (MNM) events, and potentially life-threatening conditions (PLTC), according to standard WHO
definition and criteria. Among 9,555 women with severematernalmorbidity, data on race/skin color was available for 7,139 women,
whowere further divided into two groups: 4,108 nonwhite women (2,253 black and 1,855 fromother races/skin color) and 3,031white
women. Indicators of severe maternalmorbidity according toWHO definition are shown by skin color group. Adjusted Prevalence
Ratios (PRadj - 95%CI) for SevereMaternalOutcome (SMO=MNM+MD)were estimated according to sociodemographic/obstetric
characteristics, pregnancy outcomes, and perinatal results considering race. Results. Among 7,139 women with severe maternal
morbidity evaluated, 90.5% were classified as PLTC, 8.5% as MNM, and 1.6% as MD. There was a significantly higher prevalence
of MNM and MD among white women. MNMR (maternal near miss ratio) was 9.37 per thousand live births (LB). SMOR (severe
maternal outcome ratio) was 11.08 per 1000 LB, andMMR (maternal mortality ratio) was 170.4 per 100,000 LB. Maternalmortality
tomaternal nearmiss ratiowas 1 to 5.2, irrespective ofmaternal skin color. Hypertension, themain cause ofmaternal complications,
affected mostly nonwhite women. Hemorrhage, the second more common cause of maternal complication, predominated among
white women. Nonwhite skin color was associated with a reduced risk of SMO in multivariate analysis. Conclusion. Nonwhite skin
color was associated with a lower risk for severe maternal outcomes. This result could be due to confounding factors linked to a
high rate of Brazilian miscegenation.
1. Background
Significant progress in reducing maternal mortality has been
achieved in the past 15 years, in addition to a growing aware-
ness about the burden of severematernal morbidity. Standard
definitions of potentially life-threatening conditions (PLTC)
and maternal near miss (MNM) events have enabled our
understanding of different conditions and delays related to
the quality of maternal health (Box 1 provides the full list of
WHO criteria for both conditions) [1–5].
The identification of risk factors can be effective in
providing adequate prevention and surveillance of women
with severe maternal morbidity, allowing early diagnosis and
treatment of complications [1]. It is essential that global
disparities are acknowledged among high-income and low-
income settings to improve health care. Ethnic or racial
inequalities also require investigation within nations [6, 7].
In general, white women have better maternal health
outcomes [6] while black women usually have higher mater-
nal mortality ratios [8]. It is more likely that black women
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(A) Criteria for potentially life-threatening conditions
Hemorrhagic disorders Hypertensive disorders
Abruptio placentae Severe preeclampsia
Accreta/increta/percreta placenta Eclampsia
Ectopic pregnancy Severe hypertension
Postpartum Hemorrhage Hypertensive encephalopathy
Ruptured uterus HELLP syndrome
Other systemic disorders Severe Management Indicators
Endometritis Blood transfusion
Pulmonary edema Central venous access
Respiratory failure Hysterectomy
Seizures ICU admission
Sepsis Prolonged hospital stay (>7 postpartum days)
Shock Non-anesthetic Intubation
Thrombocytopenia <100.000 Return to operating room
Thyroid crisis Surgical intervention
(B) Criteria for maternal near miss criteria
Clinical criteria
Acute cyanosis Loss of consciousness lasting ≥12 hours
Gasping Loss of consciousness AND absence of pulse/heart
beat
Respiratory rate >40 or <6/min Stroke
Shock Uncontrollable fit/total paralysis
Oliguria non-responsive to fluids or diuretics Jaundice in the presence of pre-eclampsia
Clotting failure
Laboratory-based criteria
Oxygen saturation <90% for ≥60 minutes pH <7.1
PaO2/FiO2 <200 mmHg Lactate >5 mmol/L
Creatinine ≥300 mmol/l or ≥3.5 mg/dl Acute thrombocytopenia (<50 000 platelets)
Bilirubin>100 mmol/l or > 6.0 mg/dl Loss of consciousness AND the presence of glucose
and ketoacidosis in urine
Management-based criteria
Use of continuous vasoactive drugs Intubation and ventilation for ≥60 minutes
not related to anesthesia
Hysterectomy following infection/hemorrhage Dialysis for acute renal failure
Transfusion of ≥5 units of red cell transfusion Cardio-pulmonary resuscitation (CPR)
Box 1: TheWHO criteria for potentially life-threatening conditions and maternal near miss (6).
are younger and lack a partner [6]. Furthermore, these
women usually have a lower level of school education and
less adequate prenatal care assistance [5, 8]. Recent data on
severe maternal morbidity and different races also confirmed
that black women have higher chances of developing MNM
events [9]. Other minority ethnic groups have been investi-
gated and associated with worse maternal outcomes within
nations, such asWhite-Hispanics in NewYork, USA [10], and
indigenous populations worldwide [11]. Not only race/skin
color, but also other socioeconomic and demographic factors,
preexisting conditions, and pregnancy complications are also
associated with poor maternal and perinatal outcomes [12,
13].
Another relevant challenge in studying race/ethnicity lies
in the extensive admixture of a population, for example, in a
country like Brazil, where this information is clearly difficult
to collect and interpret [14].Therefore, our aim was to explore
data on skin color variations and maternal morbidity from
the Brazilian Network for Surveillance of Severe Maternal
Morbidity study.
2. Methods
This study is a secondary data analysis from theBrazilianNet-
work for Surveillance of Severe Maternal Morbidity, a multi-
center cross-sectional study including 27 referral maternity
hospitals (private, public, university, nonuniversity) in Brazil
that had at least 1000 deliveries annually [15]. Briefly, the study
was conducted from July 2009 to June 2010. A prospective
surveillance was carried out to identify cases of maternal
death (MD),maternal near miss (MNM), and potentially life-
threatening conditions (PLTC), according to standard World
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Health Organization (WHO) definition and criteria (Box 1)
[1]. Other particularities of the study methodology and main
results have been previously published elsewhere [2, 16].
Sample size was calculated based on a previous pilot study
that obtained aMDratio of 70/100,000 live births and aMNM
ratio estimated as maximum 20% of the severe maternal
morbidity rate of 42/1000 live births [17]. Thus, the expected
prevalence of 8 MNM/1000 births with a 95% confidence
interval indicated that a surveillance of 75 thousand deliveries
was required to achieve at least 100 MD and 600 MNM.
Data collection was performed by investigators and
research assistants allocated to each hospital. Medical charts
of all women who fulfilled inclusion criteria were reviewed
after hospital discharge or death. If there was any doubt about
a diagnosis or procedure, the physician responsible for the
case was sought for elucidation. For each case identified,
a pretested and coded form was used. The form included
80 items, e.g., data on sociodemographic and economic
characteristics; obstetric history; prenatal, childbirth, and
postpartum periods; neonatal outcome, complications, and
delays in medical care.
Data was entered in the OpenClinica - version 2.5.5 -
(Akaza Research, Waltham, MA, USA) electronic platform.
The current article is an analysis of the occurrence of
severe maternal morbidity among different ethnic/skin color
categories. The study was approved by the National Research
Ethics Council (CONEP) and Institutional Review Board
of the participating locations. No contact was maintained
with participants, only chart review; therefore a waiver of
informed consent term was granted. The National Scien-
tific Technological Development Council (CNPq) and the
Department of Science and Technology of the Ministry of
Health (DECIT) funded the study.
For the current analysis, data on ethnic/race/skin color
variations were further explored. In the form, according
to information retrieved from the medical chart and self-
reported, the skin color was categorized as white, black,
indigenous, yellow, and others. In the study, there were 31.7%
of white women, 23.6% of black women, 0.2% of indigenous
women, 0.3%of yellowwomen, 19.0%of others (mainly those
from a mixed group of black and white, known as pardo),
and 25.3% of missing data. Although the rate of missing
data appears to be relatively high, it was distributed equally
between the groups and was due to lack of information in
the clinical records. Due to the small number of indigenous,
yellow, and other ethnicities, we chose to group these women
along with the black ethnic group, representing the nonwhite
group. Therefore, analysis was further conducted in two
groups: whites and nonwhites (black, indigenous, yellow, and
others).
First, we demonstrated the indicators of severe maternal
morbidity defined by the WHO (Maternal Near Miss Ratio,
Severe Maternal Outcomes Ratio, Maternal Near Miss to
Maternal Mortality ratio, and Mortality Index) according to
ethnic group. Next, we evaluated the distribution of preg-
nancy outcomes (degrees of maternal morbidity) according
to the main causes of obstetric complications and skin color,
using 𝜒2 and Fisher’s exact test to evaluate any differences
between groups. Furthermore, the risk of severe maternal
outcome (SMO = MNM + MD) was estimated by skin
color group, according to sociodemographic characteristics,
obstetric characteristics, pregnancy outcome, and perinatal
results (PR adj - 95%CI). Multiple analysis (Poisson regres-
sion) was used to assess conditions independently associated
with SMO (MNM or MD) resulting from pregnancies with
severe maternal morbidity, including also skin color as a
predictor. Data analysis was conducted by using SPSS soft-
ware version 23 (IBM, Armonk, NY, EUA) and Stata software
version 11.2 (StataCorp, College Station, TX, EUA).
3. Results
During the study period, 82,388 women underwent surveil-
lance in 27 participating hospitals, resulting in 82,144 live
births. Severe pregnancy-related complications occurred in
9,555 women. Data on skin color was available for 7,139
women (missing data: 25%). All 7,139 women were further
divided intomajor skin color groups: white, black, and others,
according to the severity ofmorbidity (Figure 1).Themajority
of cases were described as white (42.5%), followed by black
(31.6%) and others (25.9%). For further analysis of skin
color variations, two groups were considered: (1) a group of
white women and (2) a group of nonwhite women (black
+ others). Considering the continuum of morbidity, there
were significant differences among the two groups, with a
significantly higher proportion of MNM and MD among
white women (Table 1).
Allowing for additional recommended health indicators
formaternalmorbidity andmortality, there were no statistical
differences in the maternal near miss to mortality ratio and
mortality index between groups (Table 1).
The distribution of pregnancy outcomes according to
major causes of obstetric complications was also evaluated
by skin color. It revealed that the nonwhite group had a
significantly higher proportion of MD due to hyperten-
sion, infection, and combined complications than the white
group, despite the lower number of PLTC and MNM cases.
For hypertension and clinical/surgical complications (which
included the burden of the H1N1 influenza pandemic that
occurred during study period), in the continuum of severity
total numbers were higher among black women and other
minority ethnic groups, with a similar or increased propor-
tion of MD among white women (Table 2).
In order to deeply understand factors associated with a
worse maternal outcome within the continuum of severity,
we further compared cases of SMO (MNM+MD) to cases of
PLTC (less severity) among the skin color groups previously
defined.This comparison was performed for previous clinical
conditions, sociodemographic characteristics, and mater-
nal and perinatal results. Both groups showed significant
increases in the prevalence of SMO cases among previous
cardiac and thyroid diseases. Women from the nonwhite
group had less previous chronic hypertension and obesity,
while there was a higher incidence of renal disease, sickle
cell disease, and HIV/AIDS among SMO cases of nonwhite
group. White women with SMO had a higher prevalence
of other relevant conditions: low weight, neurologic disease,
cancer, and drug addiction (Table 3).
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Table 1: Indicators of severe maternal morbidity according to the WHO definition by ethnic/skin color groups.


























2.0% 3,031 - -
Total Maternal near miss: mortality ratio:MNM: 1 MD = 5.2: 1
Non-white Maternal near miss: mortality ratio:MNM: 1 MD =5.3: 1
White Maternal near miss: mortality ratio:MNM: 1 MD = 5.2: 1
Total Mortality index: MI = MD/(MNM+MD) = 0.154 = 15.4%
Non-white Mortality index: MI = MD/(MNM+MD) = 0.159 = 15.9%
White Mortality index: MI = MD/(MNM+MD) = 0.160 = 16.0%
Total Maternal mortality ratio: MMR𝑎= MD/LB X100.000 = 170.4/100 000 LB
LB: 82,144; Deliveries: 82,388; a: indicators cannot be estimated for categories of skin color because this information was not available for the total number of
livebirths; b: p=0.044 (white X non-white)
PLTC: potentially life-threatening condition; MNM: maternal near miss; MD: maternal death; MI: Mortality Index is the proportion of women with near miss
who died; SMOR: Severe Maternal Outcome Ratio is the proportion of all women delivering a live newborn who had a maternal near miss event or died
9555 women with severe 
maternal morbidity from the 
Brazilian Network
2416 women excluded due 

















7139 women included in 
the analysis
4108 Non-white women with SMM
Figure 1: Flow chart of women included in the study.
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Hemorrhage 1532 (23.7) 253 (41.6) 29 (25.0) 0.009
Non-white 676 (44.1) 112 (44.3) 14 (48.3) <0.001
White 856 (55.9) 141 (55.7) 15 (51.7) <0.001
Hypertension 4550 (70.4) 263 (43.2) 30 (25.9) <0.001
Non-white 2927 (64.3) 141 (53.6) 16 (53.3) <0.001
White 1623 (35.7) 122 (46.4) 14 (46.7) <0.001
Infection 47 (0.7) 36 (5.9) 5 (4.3) <0.001
Non-white 19 (40.4) 24 (66.7) 4 (80.0) <0.001
White 28 (59.6) 12 (33.3) 1 (20.0) <0.001
Clinical /Surgical 605 (9.3) 151 (24.8) 58 (50.0) <0.001
Non-white 310 (51.2) 64 (42.4) 25 (43.1) <0.001
White 295 (48.8) 87 (57.6) 33 (56.9) <0.001
More than one 319 (4.9) 92 (15.1) 4 (3.4) <0.001
Non-white 168 (52.7) 50 (54.3) 3 (75.0) <0.001
White 151 (47.3) 42 (45.7) 1 (25.0) <0.001
Total 6,465 608 116
PLTC: potentially life-threatening condition; MNM: maternal near miss; MD: maternal death
∗They are not mutually exclusive; the sum of categories for each group can be higher than a 100%
∗∗p-values comparing the proportions among groups adjusted for the effect of cluster design using 𝜒2 or exact tests
P-values in italic mean they are statistically significant
Table 3: Previous maternal conditions according to outcome of maternal complications by skin color group.
Previous conditions Non-white women P∗ White women p∗
PLTC SMO PLTC SMO
Any of below 1677 (48.5) 153 (48.9) 0.936 1393 (54.8) 181 (52.8) 0.592
Chronic Hypertension 646 (18.7) 39 (12.5) 0.019 429 (16.9) 51 (14.9) 0.491
Obesity 922 (26.7) 50 (16.0) 0.024 802 (31.6) 49 (14.3) <0.001
Low weight 8 (0.2) 0 0.444 10 (0.4) 6 (1.7) 0.014
Diabetes 74 (2.1) 9 (2.9) 0.434 67 (2.6) 18 (5.2) 0.076
Smoking 175 (5.1) 22 (7.0) 0.340 198 (7.8) 28 (8.2) 0.846
Cardiac disease 89 (2.6) 17 (5.4) 0.025 69 (2.7) 18 (5.2) 0.030
Respiratory disease 72 (2.1) 10 (3.2) 0.206 106 (4.2) 20 5.8) 0.166
Renal diseases 30 (0.9) 12 (3.8) <0.001 43 (1.7) 10 (2.9) 0.226
Sickle cell disease 26 (0.8) 10 (3.2) <0.001 14 (0.6) 2 (0.6) 0.954
HIV/AIDS 35 (1.0) 6 (1.9) 0.016 32 (1.3) 8 (2.3) 0.073
Thyroid diseases 29 (0.8) 8 (2.6) 0.009 45 (1.8) 12 (3.5) 0.028
Neurologic diseases 34 (1.0) 4 (1.3) 0.653 31 (1.2) 8 (2.3) 0.037
Collagenoses 14 (0.4) 3 (1.0) 0.118 20 (0.8) 6 (1.7) 0.098
Cancer 7 (0.2) 2 (0.6) 0.146 9 (0.4) 6 (1.7) 0.002
Drug addiction 38 (1.1) 8 (2.6) 0.096 27 (1.1) 15 (4.4) <0.001
Others (not specified) 132 (3.8) 37 (11.8) <0.001 149 (5.9) 49 (14.3) <0.001
Total∗ 3458 313 2540 343
PLTC: potentially life-threatening condition; SMO: severe maternal outcomes; MNM: maternal near miss; MD: maternal death; ∗p-values comparing PLTC
and SMO groups adjusted for the effect of the cluster design using 𝜒2 or exact tests; P-values in italic mean they are statistically significant
The risks of SMO were estimated, according to sociode-
mographic characteristics of women for each skin color
group, showing that increased maternal age was the most
significant factor associated with severity in both groups.
Among the nonwhite group, the lack of a partner was
protective. In white women, a higher education was a pro-
tection from severity of morbidity. Overweight and obesity
reduced the risk of SMO, irrespective of skin color (Table 4).
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Table 4: Crude estimated risks of severe maternal outcome (SMO=MNM+MD) according to sociodemographic characteristics of women
by skin color.
Characteristics Non-white women White Women
SMO PLTC PR (95%CI) SMO PLTC PR (95%CI)
Age (years)
10-19 50 716 0.82 [0.60-1.12] 56 437 0.98 [0.77-1.24]
20-29 155 1786 1 169 1288 1
30-39 115 1098 1.19 [0.90-1.57] 130 805 1.20 [0.94-1.53]
40-49 24 164 1.60 [1.10-2.33] 25 121 1.48 [1.04-2.11]
Marital status𝑎
With partner 193 1849 1 232 2380 1
Without 87 1585 0.55 [0.36-0.83] 116 1046 0.69 [0.44-1.10]
Schooling𝑏
No/Primary 118 1526 0.92 [0.36-2.36] 131 872 0.81 [0.47-1.37]
High 92 1334 0.83 [0.35-1.93] 110 1068 0.58 [0.36-0.92]
University 11 130 1 36 186 1
BMI𝑑
Low weight 22 251 0.80 [0.44-1.44] 57 245 1.38 [0.91-2.08]
Normal 49 435 1 76 478 1
Overweight 28 475 0.55 [0.34-0.90] 34 427 0.54 [0.40-0.73]
Obesity 26 543 0.45 [0.26-0.78] 31 508 0.42 [0.27-0.65]
Total 344 3764 380 2651
PLTC: potentially life-threatening condition;MNM:maternal nearmiss;MD:maternal death;PRadj=prevalence ratio adjusted for the effect of the cluster design
Missing information for: a 394+257, b 897+628, d 2279+1175 cases; PR in italic mean they are statistically significant
Furthermore, the risks of SMO were estimated according to
obstetric characteristics of women for each group, revealing
that increased risk occurred among multiparous women
(especially parity ≥ 3 in the nonwhite group), inadequate
antenatal care, preterm hospital admission, or presence of
delays (Table 5) for both groups.
For characteristics of delivery and perinatal outcomes,
results were consistently worse (increased risk of severity)
among the nonwhite group. There was an overall increased
higher risk of preterm deliveries, 5-minute Apgar scores
below 7, low birthweight, stillbirth, and neonates with inten-
sive care unit admission or transfer among women with SMO
among white compared to nonwhite women. The nonwhite
group also had a higher risk of neonatal death among SMO
cases (Table 6).
Multiple regression analysis identified conditions inde-
pendently associated with SMO.The nonwhite group signifi-
cantly reduced the risk of severity in these women (Table 7).
4. Discussion
The current analysis highlights race/skin color variations
among cases of maternal morbidity, associated with severity
of morbidity. Overall, skin color was not associated with an
increased maternal morbidity. The most significant finding
was the higher proportion of maternal deaths among the
white group, along with increased overall cases of hemor-
rhage and infection among white women. This group also
had worse results in cases of previous chronic hypertension,
renal disease, sickle cell disease, and HIV/AIDS and worse
perinatal outcomes, when compared to nonwhite women.
Nonwhite skin color reduced the risk of SMO in the mul-
tivariate analysis of factors independently associated with
increased severity.
Before going ahead with these results and their potential
implications for the knowledge on this topic, it is necessary
to remember the limitations and difficulties we have in
obtaining information on ethnicity/skin color in Brazil, first,
because according to national rules, the skin color should
be autoreported and it is not necessarily recorded in clinical
records from all hospitals. This could be an explanation
why we had relatively high missing rates for skin color
in this study, although similarly distributed according to
the severity of the morbid condition. Second, there was
a huge miscegenation in Brazil, which made difficult the
classification in a specific category.
According to data from the Center for Disease Con-
trol and Prevention (CDC), the nonwhite group had more
PLTC, in comparison to the white group. However, white
women had more severe complications (MNM and MD),
and black women had a 4-fold increased chance of dying
from pregnancy-related causes compared to white women
[18]. In the current study, the maternal mortality ratio was
170.4/100,000 LB, while according to national vital statistics
from the same period, the maternal mortality ratio in Brazil
was 72/100,000 LB in 2009 and 68.2/100,000 LB in 2010 for
the entire country [19].The 2009H1N1 influenza A pandemic
occurred at the same time period as our study. Maternity
hospitals participating in the study are also referral centers;
therefore our study had a higher mortality ratio [20].
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Table 5: Crude estimated risks of severe maternal outcome (SMO=MNM+MD) according to some obstetric characteristics of women by
skin color.
Characteristics Non-white women WhiteWomen
SMO PLTC PR (95%CI) SMO PLTC PR (95%CI)
Coverage for PN𝑎
Public 274 2932 0.85 [0.28-2.60] 277 2030 0.63 [0.39-1.03]
Private 4 65 0.58 [0.15-2.24] 7 72 0.47 [0.15-1.42]
Social security 4 36 1 28 120 1
No PN care 21 192 0.99 [0.34-2.82] 25 131 0.85 [0.31-2.34]
Parity𝑏
0 111 1861 1 158 1280 1
1-2 149 1385 1.73 [1.35-2.21] 165 1042 1.24 [1.07-1.45]
≥3 79 511 2.38 [1.71-3.32] 55 324 1.32 [0.88-1.97]
Prenatal care (visits)𝑐
No 28 257 1.86 [1.18-2.92] 36 153 2.31 [1.15-4.65]
1-5 122 1243 1.69 [1.35-2.10] 112 777 1.53 [1.20-1.96]
6 or more 93 1663 1 123 1370 1
Gestational age at termination of pregnancy𝑑
< 22 weeks 26 177 4.06 [1.83-8.99] 42 165 3.67 [1.80-7.48]
22-27 32 169 5.04 [2.88-8.83] 51 164 4.29 [2.45-7.50]
28-33 84 684 3.46 [2.42-4.95] 82 500 2.55 [1.64-3.96]
34-36 60 754 2.33 [1.43-3.80] 62 462 2.14 [1.42-3.22]
≥ 37 58 1779 1 71 1212 1
Still pregnant 74 114 12.47 [8.05-19.30] 58 86 7.28 [4.02-13.17]
Delays𝑒
With any delay 237 1961 1.97 [1.45-2.69] 240 1112 2.25 [1.69-3.00]
No delay 93 1609 1 124 1447 1
Total 344 3764 380 2651
Missing information for: a 580+341; b 12+7; c 702+460; d 97+76; e 208+108 cases
PRadj= prevalence ratio adjusted for the effect of the cluster design
PR in italic mean they are statistically significant
Other examples from low-income settings present even
higher rates ofmaternal mortality [3, 4, 7]. A study conducted
in a hospital in Nigeria showed a maternal mortality ratio of
1908/100 000 LB, which was 11-fold higher than results found
in the current study, and a severe maternal outcome ratio of
218/1000 LB, a value that was 20-fold higher than our findings
[21].
Underlying social-demographic conditions and previous
clinical comorbidities are likely to influence maternal and
perinatal outcomes [5, 8]. Low level of school education is
considered a risk factor for SMO [5]. In the current study,
white women with complete secondary school education
had a lower risk of developing SMO. Multiparous nonwhite
women had a higher risk of SMO, in accordance with the
literature [2].
Regardless of skin color, womenof advancedmaternal age
had a higher risk of developing severe complications (SMO).
Similar reports in the literature have described that maternal
age over 40 years increases the odds of complications [22–27].
CDC data indicated that black women at advanced maternal
age had a higher mortality rate [18]. On the other hand,
obesity and overweight were protective factors for SMO.
Aprevious report ondata fromBrazil showed thatwomen
with underlying disorders had a higher risk of near miss
events and nonwhites had more chronic diseases than whites
[5]. In our study, the nonwhite group who developed SMO
had a lower prevalence of HIV/AIDS and chronic hyperten-
sion. In this group, the complication that caused a higher
rate of PLTC was mostly hypertension. Nonwhite women
have a greater trend towards hypertension diagnosed at the
beginning of pregnancy and also of developing preeclampsia
[22, 23]. Although white women had more PLTC due to
infection, nonwhite women had more severe complications
and deaths related to infection, in our sample.
A main concern when considering risk factors for worse
outcomes is to identify such conditions and provide adequate
care, awareness, and prompt diagnosis of complications, in
order to avoid delays.These delays can be organized as related
to the delay in deciding to seek care by the individual and/or
family (called phase I delay); delay in reaching an adequate
health care facility (phase II); and delay in receiving adequate
care at the facility (phase III) [15, 28].The present study shows
once more that severe maternal outcome is associated with
the occurrence of delays, among nonwhite color and even
more among white women.
A study in the United Kingdom showed that starting
prenatal care at a later gestational age or no prenatal care
may be associated with maternal death in ethnic minority
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Table 6: Crude estimated risks of severematernal outcome (SMO=MNM+MD) according to pregnancy termination and perinatal outcomes
by skin color.
Characteristics Non-white women White Women
SMO PLTC PR (95%CI) SMO PLTC PR (95%CI)
GA at delivery𝑎
Preterm (<37 weeks) 176 1448 2.67 [1.93-3.71] 190 1017 2.12 [1.54-2.93]
Term 82 1942 1 107 1336 1
Still pregnant 28 206 2.95 [1.76-4.97] 43 206 2.33 [1.24-4.38]
Mode of pregnancy termination𝑏
Vaginal birth 70 805 1 63 749 1
Cesarean section 220 2554 0.99 [0.64-1.53] 238 1540 1.73 [0.88-3.37]
Abortion/ectopic 24 186 1.43 [0.56-3.64] 32 152 2.24 [0.79-6.34]
Still pregnant 28 206 1.50 [0.90-2.50] 43 208 2.21 [0.88-5.55]
Apgar score 5𝑡ℎ min𝑐
<7 27 87 4.71 [3.28-6.77] 31 80 3.22 [2.24-4.63]
≥7 164 3098 1 199 2098 1
Birth weight𝑑
<2.500 g 136 1227 2.33 [1.69-3.22] 148 841 1.99 [1.38-2.87]
≥2.500 g 92 2058 1 114 1403 1
Neonatal condition at birth𝑒
Live birth 204 3212 1 249 2205 1
Still birth 53 107 5.55 [3.88-7.94] 34 75 3.07 [1.88-5.04]
Neonatal outcomes𝑓
Discharge 118 2449 1 149 1586 1
Admitted or transferred 72 628 2.24 [1.56-3.20] 79 538 1.49 [1.02-2.17]
Neonatal death 8 65 2.38 [1.52-3.75] 14 67 2.01 [0.98-4.15]
Total 344 3764 380 2651
Missing information for: a 226+132; b 15+6; c 732+623; d 595+525; e 532+468; f 768+598 cases
PRadj= prevalence ratio adjusted for the effect of the cluster design; PR in italic mean they are statistically significant
Table 7: Conditions associated with SMO (MNM or MD) as outcome of pregnancy with severe maternal morbidity (multiple analysis by
Poisson regression∗).
Model/ Condition PRadj 95% CI p
Model [n = 4,981] for Severe Maternal Outcome
Other conditions 2.53 2.09–3.05 <0.001
Any delay 1.72 1.44–2.05 <0.001
Gestational age at admission (<37 weeks or postpartum) 2.83 1.99–4.01 <0.001
Obesity 0.48 0.37–0.62 <0.001
Number of previous deliveries (≥1) 1.33 1.10–1.62 0.005
Skin color/ethnicity (non-white) 0.61 0.44–0.85 0.005
Marital status (Without partner) 0.56 0.38–0.83 0.005
Renal diseases 1.89 1.16–3.05 0.012
Neoplasms 1.79 1.09–2.96 0.024
Sickle cell diseases 2.01 1.09–3.69 0.026
Schooling (up to primary) 1.22 1.02–1.47 0.033
Chronic hypertension 0.71 0.51–0.99 0.049
∗Analysis considering cluster design (center)
Predictors entering themodels: age (years);marital status (with partner: 0/without: 1); schooling (up to primary: 1/ high school or higher: 0); skin color/ethnicity
(White: 0/ non-white: 1); financial support for prenatal care (public: 0/ other: 1); number of previous deliveries (0/ ≥1: 1); number of prenatal visits (< 6: 1/ ≥6:
0); gestational age at admission (< 37 weeks or postpartum: 1/ ≥37 sem.: 0); any delay (Yes: 1/ No: 0); previous pathological conditions (Yes: 1/No: 0); chronic
hypertension (Yes: 1/No: 0); obesity (Yes: 1/No: 0); low weight (Yes: 1/No: 0); diabetes (Yes: 1/No: 0); smoking (Yes: 1/No: 0); cardiac diseases (Yes: 1/No: 0);
respiratory diseases (Yes: 1/No: 0); renal diseases (Yes: 1/No: 0); sickle cell diseases (Yes: 1/No: 0); HIV/Aids (Yes: 1/No: 0); thyroid diseases (Yes: 1/No: 0);
neurological diseases/epilepsy (Yes: 1/No: 0); collagenoses (Yes: 1/No: 0); neoplasms (Yes: 1/No: 0); drug addiction (Yes: 1/No: 0); other conditions (Yes: 1/No: 0).
BMI was not included in the models due to the high number of missing values
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groups [29]. In contrast, a study in Holland did not show any
association between late prenatal care or no prenatal care and
maternal death [30]. Another study from the United King-
dom showed that pregnancy in black women is diagnosed
later, delaying initiation of prenatal care and consequently
delaying access to prenatal care [31]. Nevertheless, in our
study the lack of prenatal care was a risk factor for SMO
among whites. Regardless of ethnicity, the quality of prenatal
care is fundamental. On the other hand, women who have
many medical prenatal visits usually have some pathological
condition or risk justifying this excessive number [5]. Quality
assessment of prenatal care is not easy, although there is a
suspicion that it may be directly influenced by the social class
and ethnic/skin color group of the health service user.
Considering perinatal outcomes, nonwhite group who
developed SMO had a higher risk of delivering preterm
infants. Furthermore, SMO was associated with a higher
occurrence of fetal death, 5-minute Apgar scores lower than
7, low birthweight (<2.500g), need for hospital admission, or
transfer of the newborn infant or neonatal death, and these
risk estimateswere slightly higher for nonwhite than forwhite
women. Two previous Brazilian studies have identified that
black women have a higher incidence of low birthweight
infants [5, 19].
This network study may have some limitations in deter-
mining skin color, since data was captured from medical
charts. Information may have been extracted by woman
self-report or defined by the medical provider of obstetric
care or even the hospital personnel who registered obstetric
care management. Furthermore, due to miscegenation in
the country, some characteristics that are specific to the
black people may be missing, as we observed in some
studies conducted in countries with a lower proportion of
miscegenation.
In our study, women from the white group were the most
affected by SMO, a result that is surprising taking into account
all the previously available evidence. We tried to explore the
possible interrelationships with other variables that could
explain these results, including the difficulty of classifying
race/skin color by the women themselves, what could also
be seen as a limitation of the study. However, another
important point must be also considered: the data came
from a prospective surveillance performed during a one-
year period in 27 referral maternity hospitals in the country,
mainly university tertiary hospitals. We cannot exclude the
possibility that a differential access to these facilities was
experienced according to race/ethnicity, with higher system
and personal difficulties for nonwhite women having access
to these more resourceful facilities in dealing with their
pregnancy complications. This reflects the importance of
studies addressing different risk factors for worse outcomes in
low and middle-income settings. Local characteristics, such
as significant miscegenation, need to be considered when
studying skin color.
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A Zanette, Márcia M Aquino, Maria H Ohnuma, Rosiane
Mattar, and Felipe F Campanharo.
References
[1] L. Say, J. P. Souza, and R. C. Pattinson, “Maternal near
miss—towards a standard tool for monitoring quality of mater-
nal health care,” Best Practice & Research Clinical Obstetrics &
Gynaecology, vol. 23, no. 3, pp. 287–296, 2009.
[2] J. G. Cecatti, M. L. Costa, S. M. Haddad et al., “Network for
Surveillance of Severe MaternalMorbidity: a powerful national
collaboration generating data on maternal health outcomes
and care,” BJOG: An International Journal of Obstetrics &
Gynaecology, vol. 123, no. 6, pp. 946–953, 2016.
[3] TheWorldBank, Trends inMaternalMortality: 1990 to 2015. In:
World Health Organization; 2010, p. 1–55, http://www.who.int/
reproductivehealth/publications/monitoring/maternal-mortality-
2015/en/.
[4] WHO, WHO Maternal mortality, World Health Organization;
2016, http://www.who.int/mediacentre/factsheets/fs348/en/.
[5] A. L. Martins, “Nearmiss and black women,” Saúde e Sociedade,
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